China's first personalized neoantigen-targeted cancer vaccine receives NMPA's clinical trial approval

/PRNewswire/ -- According the latest data released at the Clinical Trials Implied Approval section on the website of China's Center for Drug Evaluation (CDE)...

Related Keywords

Beijing ,China ,Likang ,Jiangsu ,Chinese , ,National Medical Products Administration ,Likang Life Sciences ,China Center ,Clinical Trials Implied Approval ,Drug Evaluation ,Life Sciences ,